US-EU Trade Deal Could Drive Up Drug Prices and Shift Global Influence
TL;DR Summary
The US-EU trade deal may lead to increased drug prices and limited access due to a 15% tariff on European-branded drugs, potentially costing the industry up to $19 billion and affecting the cost of imported pharmaceuticals and raw materials, with ongoing negotiations and policy uncertainties.
- Drug prices likely to rise with tariffs on EU Axios
- Trump’s Tariffs on Medicines From Europe Stand to Cost Drugmakers Billions The New York Times
- Fact Sheet: The United States and European Union Reach Massive Trade Deal The White House (.gov)
- Trump's trade deal with the EU: What it means for your wallet USA Today
- Brutal US Trade Deal Stirs EU Soul-Searching Over Loss of Clout Bloomberg
Reading Insights
Total Reads
0
Unique Readers
23
Time Saved
3 min
vs 3 min read
Condensed
92%
572 → 45 words
Want the full story? Read the original article
Read on Axios